© 2019 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
Swiss researchers analyzed shifts in kidney function among those switching from the old form of the HIV medication to the new one.
Highlights from HIV and hepatitis C research presented at the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston
The once-daily regimen includes the integrase inhibitor bictegravir plus the contents of Descovy (emtricitabine/tenofovir alafenamide).
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
